These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

861 related articles for article (PubMed ID: 9618419)

  • 1. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW; Bergman J
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions.
    Jutkiewicz EM; Bergman J
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1008-15. PubMed ID: 15292458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434.
    Platt DM; Rowlett JK; Spealman RD
    J Pharmacol Exp Ther; 2000 Jun; 293(3):1017-26. PubMed ID: 10869406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral effects of cocaine: interactions with D1 dopaminergic antagonists and agonists in mice and squirrel monkeys.
    Katz JL; Kopajtic TA; Myers KA; Mitkus RJ; Chider M
    J Pharmacol Exp Ther; 1999 Oct; 291(1):265-79. PubMed ID: 10490913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats.
    Filip M; Przegaliński E
    Pol J Pharmacol; 1997; 49(1):21-30. PubMed ID: 9431548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of dopamine D1 and D2 receptor agonists on schedule-controlled behavior of squirrel monkeys.
    Bergman J; Rosenzweig-Lipson S; Spealman RD
    J Pharmacol Exp Ther; 1995 Apr; 273(1):40-8. PubMed ID: 7714795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections.
    Witkin JM; Nichols DE; Terry P; Katz JL
    J Pharmacol Exp Ther; 1991 May; 257(2):706-13. PubMed ID: 1674533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys.
    Spealman RD
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1128-37. PubMed ID: 8819495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists.
    Khroyan TV; Barrett-Larimore RL; Rowlett JK; Spealman RD
    J Pharmacol Exp Ther; 2000 Aug; 294(2):680-7. PubMed ID: 10900248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification by dopaminergic drugs of choice behavior under concurrent schedules of intravenous saline and food delivery in monkeys.
    Gasior M; Paronis CA; Bergman J
    J Pharmacol Exp Ther; 2004 Jan; 308(1):249-59. PubMed ID: 14563783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes.
    Spealman RD; Bergman J; Madras BK; Melia KF
    J Pharmacol Exp Ther; 1991 Sep; 258(3):945-53. PubMed ID: 1679852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of the discriminative-stimulus effects of GBR 12909.
    Melia KF; Spealman RD
    J Pharmacol Exp Ther; 1991 Aug; 258(2):626-32. PubMed ID: 1678014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of the behavioral effects of the selective dopamine D2 agonist (+)-4-propyl-9-hydroxynaphthoxazine by dopamine antagonists in monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1039-46. PubMed ID: 8099614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus properties of D1 and D2 dopamine agonists in rats.
    Kamien JB; Goldberg LI; Woolverton WL
    J Pharmacol Exp Ther; 1987 Sep; 242(3):804-11. PubMed ID: 2958620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats.
    Munzar P; Goldberg SR
    Psychopharmacology (Berl); 2000 Feb; 148(2):209-16. PubMed ID: 10663437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
    Ralph RJ; Caine SB
    J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
    Cory-Slechta DA; Widzowski DV; Newland MC
    J Pharmacol Exp Ther; 1989 Sep; 250(3):800-8. PubMed ID: 2789282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.